Skip to main content
SpringerLink
Log in

Costs of treatments for rheumatic disorders vary in US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2015 US dollars

Reference

  • Chastek B, et al. A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients. Advances in Therapy : 12 Mar 2016. Available from: URL: http://doi.org/10.1007/s12325-016-0312-y

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs of treatments for rheumatic disorders vary in US. PharmacoEcon Outcomes News 749, 13 (2016). https://doi.org/10.1007/s40274-016-2900-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2900-0

Search

Navigation